Long-term outcome of resuming anticoagulation after anticoagulation-associated intracerebral hemorrhage

INTRODUCTION: The risk and benefit of restarting oral anticoagulation (OAC) therapy among patients with atrial fibrillation or flutter (AF) and an episode of anticoagulation-associated intracerebral hemorrhage (ICH) remain unclear. Whether or not to resume OAC after an OAC-associated ICH will remain...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:eNeurologicalSci
Auteurs principaux: Sadighi, Alireza, Wasko, Lisa, DiCristina, Heather, Wagner, Thomas, Wright, Kathryn, Capone, Kellie, Monczewski, Maureen, Kester, Margaret, Bourdages, George, Griessenauer, Christoph, Zand, Ramin
Format: Artigo
Langue:Inglês
Publié: Elsevier 2020
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7037578/
https://ncbi.nlm.nih.gov/pubmed/32123759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ensci.2020.100222
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires